The information on this page is for informational purposes only and does not constitute medical advice. Consult your genetic counselor or specialist physician for treatment decisions.

HRAS

—HRas Proto-Oncogene

Chromosome: 11

Location: 11:532242-537343

OMIM: 190020

Ensembl: ENSG00000174775

Official·OMIM:190020 Official·ENSG00000174775

Encodes GTPase signaling protein. Mutations cause Costello syndrome.

Treatment Roadmap — HRAS

Preclinical

Phase 1

Phase 2

10 trial

Phase 3

Approved

Clinical trials have approximately 10% success rate. This roadmap shows the current status, not guaranteed outcomes.

Associated Diseases

Costello Syndrome

Autosomal DominantPrevalence: 1/1000000oncologic

Official·OMIM:218040 Official·ORPHA3071

Summary

Clinical Trial

Approved Therapy

Registered Variant